Neurotoxicity and excitatory amino acid antagonists

Related Experiment Video

Updated: Nov 6, 2026

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models
10:46

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models

Published on: May 3, 2017

A Schousboe1, A Frandsen, P Wahl

  • 1Department of Biology, Royal Danish School of Pharmacy, Copenhagen.

Neurotoxicology
|January 1, 1994
PubMed

Insights

Excitatory amino acids like glutamate cause neurotoxicity by increasing intracellular calcium (Ca2+). Different receptors mediate these effects, suggesting excitation and neurotoxicity are not always directly linked.

Area of Science:

  • Neuroscience
  • Neurobiology
  • Cellular Biology

Background:

  • Excitatory amino acids (EAAs) are crucial neurotransmitters in the central nervous system.
  • Dysregulation of EAA signaling is implicated in various neurological disorders and neuronal damage.

Purpose of the Study:

  • To investigate the mechanisms underlying the cytotoxic effects of different EAAs in cultured neocortical neurons.
  • To elucidate the role of intracellular calcium (Ca2+) concentration and specific receptor subtypes in EAA-induced neurotoxicity.

Main Methods:

  • Primary neuronal cultures of neocortical neurons were utilized.
  • Intracellular Ca2+ concentration was measured following EAA exposure.
  • Selective receptor antagonists (NMDA, non-NMDA, AMPA/kainate) were employed to differentiate receptor-mediated effects.

Main Results:

  • All tested EAAs (glutamate, aspartate, NMDA, AMPA, kainate) increased intracellular Ca2+, a prerequisite for cytotoxicity.
  • Glutamate and NMDA affected both Ca2+ influx and intracellular release, while AMPA and kainate primarily increased influx.
  • Glutamate cytotoxicity involved both NMDA and non-NMDA receptors.
  • AMPA receptor agonists/antagonists showed that excitation and neurotoxicity are not always simply correlated.

Conclusions:

  • Intracellular Ca2+ elevation is a common pathway for EAA-induced neurotoxicity.
  • Different EAAs and their respective receptors contribute distinct mechanisms to neuronal damage.
  • The relationship between neuronal excitation and neurotoxicity is complex and concentration-dependent.

More Related Videos

Modeling Neuronal Death and Degeneration in Mouse Primary Cerebellar Granule Neurons10:36

Modeling Neuronal Death and Degeneration in Mouse Primary Cerebellar Granule Neurons

Published on: November 6, 2017

Adaptation of Microelectrode Array Technology for the Study of Anesthesia-induced Neurotoxicity in the Intact Piglet Brain08:23

Adaptation of Microelectrode Array Technology for the Study of Anesthesia-induced Neurotoxicity in the Intact Piglet Brain

Published on: May 12, 2018

Related Concept Videos

Excitatory and Inhibitory Effects of Neurotransmitters01:29

Excitatory and Inhibitory Effects of Neurotransmitters

When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of specific...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...